SCYNEXIS, Inc. Preferred Stock Dividends and Other Adjustments
SCYNEXIS, Inc. (SCYX) reported Preferred Stock Dividends and Other Adjustments of $0 for the 3-month period ending 2015-09-30, per its 10-Q filed 2015-11-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:PreferredStockDividendsAndOtherAdjustments · last filed 2015-11-13
- SCYNEXIS, Inc. preferred stock dividends and other adjustments for the quarter ending 2015-09-30 was $0.00.
- SCYNEXIS, Inc. preferred stock dividends and other adjustments for the quarter ending 2015-06-30 was $0.00, a 100.00% decline year-over-year.
- SCYNEXIS, Inc. preferred stock dividends and other adjustments for the quarter ending 2014-09-30 was $0.00.
- SCYNEXIS, Inc. preferred stock dividends and other adjustments for the quarter ending 2014-06-30 was $262.00K.
| Period end | Preferred Stock Dividends and Other Adjustments 3 month | Preferred Stock Dividends and Other Adjustments 6 month | Preferred Stock Dividends and Other Adjustments 9 month |
|---|---|---|---|
| 2015-09-30 | $0.00 10-Q · filed 2015-11-13 | $0.00 derived: sum of 2 quarters · filed 2015-11-13 | $0.00 10-Q · filed 2015-11-13 |
| 2015-06-30 | $0.00 10-Q · filed 2015-08-19 | $0.00 10-Q · filed 2015-08-19 | |
| 2014-09-30 | $0.00 10-Q · filed 2015-11-13 | $262.00K derived: sum of 2 quarters · filed 2015-11-13 | $1.63M 10-Q · filed 2015-11-13 |
| 2014-06-30 | $262.00K 10-Q · filed 2015-08-19 | $1.94M 10-Q · filed 2015-08-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |